Rituxan (rituximab) - Roche
Effective combined immunotherapy for severe hemolytic disease of the fetus. (PubMed, Transfusion) - Oct 21, 2026 - "This case series presents a novel, safe personalized prophylactic and therapeutic approach that may delay anemia onset and reduce invasive procedures in high-risk patients with limited options and resulted in healthy neonates without apparent comorbidities." 
Journal • Hematological Disorders • Thrombocytopenia
http://www.ncbi.nlm.nih.gov/pubmed/42899548
 
Annina Capraru; Behrouz Mansouri Taleghani; Luigi Raio; Martin Mueller; Michael Daskalakis; Sacha Zeerleder
 
Oct 21, 2026
 
Prev Next